What is the current annual EBITDA of ELV?

As of today, ELV annual EBITDA is $8.26B

What is 1-year change in ELV annual EBITDA?

ELV annual EBITDA is down -11.20% year-over-year

What is 3-year change in ELV annual EBITDA?

ELV annual EBITDA is down -10.99% over the past 3 years

How far is ELV annual EBITDA from its all-time high?

ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on December 31, 2023

How does ELV annual EBITDA rank versus sector peers?

ELV annual EBITDA is higher than 98.23% of companies in Healthcare sector

When is ELV next annual earnings release?

The next annual earnings release for ELV is on January 28, 2027

What is the current quarterly EBITDA of ELV?

As of today, ELV quarterly EBITDA is $2.16B

What is ELV quarterly EBITDA most recent change?

ELV quarterly EBITDA was down -6.34% on September 30, 2026

What is 1-year change in ELV quarterly EBITDA?

ELV quarterly EBITDA is up +20.30% year-over-year

How far is ELV quarterly EBITDA from its all-time high?

ELV quarterly EBITDA is currently -51.82% below its historical high of $4.48B set on December 31, 2009

How does ELV quarterly EBITDA rank versus sector peers?

ELV quarterly EBITDA is higher than 98.08% of companies in Healthcare sector

When is ELV next earnings release?

The next earnings release for ELV is on January 28, 2027

What is the current TTM EBITDA of ELV?

As of today, ELV TTM EBITDA is $7.74B

What is ELV TTM EBITDA most recent change?

ELV TTM EBITDA was up +4.94% on September 30, 2026

What is 1-year change in ELV TTM EBITDA?

ELV TTM EBITDA is down -10.42% year-over-year

How far is ELV TTM EBITDA from its all-time high?

ELV TTM EBITDA is currently -23.35% below its historical high of $10.10B set on June 30, 2024

How does ELV TTM EBITDA rank versus sector peers?

ELV TTM EBITDA is higher than 97.98% of companies in Healthcare sector

When is ELV next earnings release?

The next earnings release for ELV is on January 28, 2027

ELV EBITDA History & Chart Since 2002

Annual EBITDA

$8.26B$1.04B-11.20%

December 31, 2025

Summary

Current Value: As of today, ELV annual EBITDA is $8.26B, down -11.20% on December 31, 2025
Historical Performance: ELV annual EBITDA is down -10.99% over the past 3 years, up +11.69% over the past 5 years
All-Time High Comparison: ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on December 31, 2023
3-Year Low Comparison: ELV annual EBITDA is at its 3-year low
Sector Comparison: ELV annual EBITDA is higher than 98.23% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ELV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$8.26B	-11.2%	-11.0%	+11.7%	+66.6%
Quarterly EBITDA	Sep 30, 26	$2.16B	+20.3%	+3.7%	-8.1%	+80.2%
TTM EBITDA	Sep 30, 26	$7.74B	-10.4%	-19.0%	-7.5%	+59.6%
Price	Oct 30, 26	$420.07	+30.5%	-6.2%	-3.5%	+511.6%
PE Ratio	Oct 30, 26	17.91	+36.0%	+0.5%	-8.3%	+99.0%
Annual Revenue	Dec 31, 25	$199.13B	+12.6%	+27.2%	+63.4%	+238.4%
Annual EPS	Dec 31, 25	$25.21	-1.8%	+3.9%	+40.2%	+263.3%
	Dec 31, 25	$6.71B	-15.1%	-11.7%	+7.6%	+54.1%
Annual Net Income	Dec 31, 25	$5.66B	-5.2%	-3.9%	+23.8%	+96.1%

EBITDA Highs

ELV Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$9.46B	Dec 31, 23	-12.7%
5Y	$9.46B	Dec 31, 23	-12.7%
All	$9.46B	Dec 31, 23	-12.7%

EBITDA Lows

ELV Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$8.26B	Dec 31, 25	at low
5Y	$7.39B	N/A	+11.7%
All	$964.60M	Dec 31, 02	+755.9%

EBITDA History

Year	Value	Change
2025	$8.26B	-11.2%
2024	$9.30B	-1.7%
2023	$9.46B	+2.0%
2022	$9.28B	+0.5%
2021	$9.23B	+24.8%
2020	$7.39B	+3.8%
2019	$7.12B	+14.8%
2018	$6.20B	+27.7%
2017	$4.85B	-11.2%
2016	$5.47B	-1.3%
2015	$5.54B	+6.1%
2014	$5.22B	+9.9%

Year	Value	Change
2013	$4.75B	+3.3%
2012	$4.60B	+0.1%
2011	$4.60B	-7.3%
2010	$4.95B	-37.7%
2009	$7.96B	+115.4%
2008	$3.69B	-36.8%
2007	$5.84B	+5.9%
2006	$5.52B	+22.0%
2005	$4.52B	+162.7%
2004	$1.72B	+17.6%
2003	$1.46B	+51.8%
2002	$964.60M	-

FAQ

What is the current annual EBITDA of ELV?: As of today, ELV annual EBITDA is $8.26B
What is 1-year change in ELV annual EBITDA?: ELV annual EBITDA is down -11.20% year-over-year
What is 3-year change in ELV annual EBITDA?: ELV annual EBITDA is down -10.99% over the past 3 years
How far is ELV annual EBITDA from its all-time high?: ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on December 31, 2023
How does ELV annual EBITDA rank versus sector peers?: ELV annual EBITDA is higher than 98.23% of companies in Healthcare sector
When is ELV next annual earnings release?: The next annual earnings release for ELV is on January 28, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$2.16B$146.00M-6.34%

September 30, 2026

Summary

Current Value: As of today, ELV quarterly EBITDA is $2.16B, down -6.34% on September 30, 2026
Historical Performance: ELV quarterly EBITDA is up +20.30% year-over-year, up +3.70% over the past 3 years
All-Time High Comparison: ELV quarterly EBITDA is currently -51.82% below its historical high of $4.48B set on December 31, 2009
3-Year Low Comparison: ELV quarterly EBITDA is +247.34% above its 3-year low of $621.00M reached on December 31, 2025
Sector Comparison: ELV quarterly EBITDA is higher than 98.08% of companies in Healthcare sector

Performance

ELV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$2.16B	-6.3%	+20.3%	+3.7%	-8.1%
Annual EBITDA	Dec 31, 25	$8.26B	–	-11.2%	-11.0%	+11.7%
TTM EBITDA	Sep 30, 26	$7.74B	+4.9%	-10.4%	-19.0%	-7.5%
Price	Oct 30, 26	$420.07	+11.6%	+30.5%	-6.2%	-3.5%
PE Ratio	Oct 30, 26	17.91	+7.0%	+36.0%	+0.5%	-8.3%
Quarterly Revenue	Sep 30, 26	$51.43B	+1.9%	+1.4%	+20.0%	+43.6%
Quarterly EPS	Sep 30, 26	$6.27	-6.6%	+18.0%	+15.1%	+2.3%
	Sep 30, 26	$1.79B	-7.4%	+27.6%	+8.5%	-10.1%
Quarterly Net Income	Sep 30, 26	$1.34B	-7.6%	+13.1%	+3.3%	-10.6%

Quarterly EBITDA Highs

ELV Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$2.66B	Mar 31, 26	-18.9%
3Y	$3.32B	Jun 30, 24	-35.0%
5Y	$3.32B	Jun 30, 24	-35.0%
All	$4.48B	Dec 31, 09	-51.8%

Quarterly EBITDA Lows

ELV Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$621.00M	Dec 31, 25	+247.3%
3Y	$621.00M	Dec 31, 25	+247.3%
5Y	$621.00M	Dec 31, 25	+247.3%
All	$215.20M	Jun 30, 02	+902.3%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$2.16B	-6.3%
Jun 2026	$2.30B	-13.4%
Mar 2026	$2.66B	+328.0%
Dec 2025	$621.00M	-65.4%
Sep 2025	$1.79B	-32.9%
Jun 2025	$2.67B	-15.7%
Mar 2025	$3.17B	+215.7%
Dec 2024	$1.00B	-41.0%
Sep 2024	$1.70B	-48.8%
Jun 2024	$3.32B	+1.6%
Mar 2024	$3.27B	+129.5%
Dec 2023	$1.43B	-31.5%
Sep 2023	$2.08B	-27.6%
Jun 2023	$2.87B	-6.7%
Mar 2023	$3.08B	+103.0%
Dec 2022	$1.52B	-41.1%
Sep 2022	$2.58B	+2.5%
Jun 2022	$2.52B	-5.6%
Mar 2022	$2.66B	+51.4%
Dec 2021	$1.76B	-25.0%
Sep 2021	$2.35B	-11.8%
Jun 2021	$2.66B	+8.3%
Mar 2021	$2.46B	+172.8%
Dec 2020	$901.00M	+29.3%
Sep 2020	$697.00M	-79.7%
Jun 2020	$3.44B	+45.6%
Mar 2020	$2.36B	+75.5%
Dec 2019	$1.34B	-24.9%
Sep 2019	$1.79B	+2.3%
Jun 2019	$1.75B	-21.7%
Mar 2019	$2.23B	+168.8%
Dec 2018	$831.00M	-45.7%
Sep 2018	$1.53B	-14.5%
Jun 2018	$1.79B	-12.7%
Mar 2018	$2.05B	+482.9%
Dec 2017	$351.70M	-73.8%
Sep 2017	$1.34B	-5.8%
Jun 2017	$1.42B	-17.9%
Mar 2017	$1.74B	+94.8%
Dec 2016	$891.00M	-34.7%
Sep 2016	$1.36B	-18.5%
Jun 2016	$1.67B	+8.9%
Mar 2016	$1.54B	+153.8%
Dec 2015	$605.60M	-45.0%
Sep 2015	$1.10B	-46.3%
Jun 2015	$2.05B	+14.9%
Mar 2015	$1.78B	+62.8%

Month	Value	Change
Dec 2014	$1.10B	-15.8%
Sep 2014	$1.30B	-11.9%
Jun 2014	$1.48B	+9.6%
Mar 2014	$1.35B	+93.1%
Dec 2013	$697.50M	-37.2%
Sep 2013	$1.11B	-22.7%
Jun 2013	$1.44B	-3.9%
Mar 2013	$1.49B	+121.6%
Dec 2012	$674.50M	-44.4%
Sep 2012	$1.21B	-1.5%
Jun 2012	$1.23B	-17.3%
Mar 2012	$1.49B	+126.2%
Dec 2011	$658.00M	-45.0%
Sep 2011	$1.20B	+3.0%
Jun 2011	$1.16B	-26.3%
Mar 2011	$1.58B	+73.3%
Dec 2010	$910.40M	-29.6%
Sep 2010	$1.29B	+1.2%
Jun 2010	$1.28B	-13.4%
Mar 2010	$1.47B	-67.1%
Dec 2009	$4.48B	+256.3%
Sep 2009	$1.26B	+5.2%
Jun 2009	$1.19B	+16.0%
Mar 2009	$1.03B	+60.2%
Dec 2008	$642.60M	-7.7%
Sep 2008	$696.20M	-47.7%
Jun 2008	$1.33B	+30.0%
Mar 2008	$1.02B	-30.2%
Dec 2007	$1.47B	-3.4%
Sep 2007	$1.52B	+3.4%
Jun 2007	$1.47B	+5.6%
Mar 2007	$1.39B	-3.3%
Dec 2006	$1.44B	+2.3%
Sep 2006	$1.41B	+3.9%
Jun 2006	$1.35B	+2.5%
Mar 2006	$1.32B	+10.3%
Dec 2005	$1.20B	+1.5%
Sep 2005	$1.18B	+10.0%
Jun 2005	$1.07B	0.0%
Mar 2005	$1.07B	+114.1%
Dec 2004	$501.20M	+44.1%
Sep 2004	$347.90M	-18.3%
Jun 2004	$425.90M	-5.6%
Mar 2004	$451.40M	+38.7%
Dec 2002	$325.40M	+18.5%
Sep 2002	$274.50M	+27.6%
Jun 2002	$215.20M	-

FAQ

What is the current quarterly EBITDA of ELV?: As of today, ELV quarterly EBITDA is $2.16B
What is ELV quarterly EBITDA most recent change?: ELV quarterly EBITDA was down -6.34% on September 30, 2026
What is 1-year change in ELV quarterly EBITDA?: ELV quarterly EBITDA is up +20.30% year-over-year
How far is ELV quarterly EBITDA from its all-time high?: ELV quarterly EBITDA is currently -51.82% below its historical high of $4.48B set on December 31, 2009
How does ELV quarterly EBITDA rank versus sector peers?: ELV quarterly EBITDA is higher than 98.08% of companies in Healthcare sector
When is ELV next earnings release?: The next earnings release for ELV is on January 28, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$7.74B$364.00M+4.94%

September 30, 2026

Summary

Current Value: As of today, ELV TTM EBITDA is $7.74B, up +4.94% on September 30, 2026
Historical Performance: ELV TTM EBITDA is down -10.42% year-over-year, down -18.99% over the past 3 years
All-Time High Comparison: ELV TTM EBITDA is currently -23.35% below its historical high of $10.10B set on June 30, 2024
3-Year Low Comparison: ELV TTM EBITDA is +4.94% above its 3-year low of $7.38B reached on June 30, 2026
Sector Comparison: ELV TTM EBITDA is higher than 97.98% of companies in Healthcare sector

Performance

ELV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$7.74B	+4.9%	-10.4%	-19.0%	-7.5%
Annual EBITDA	Dec 31, 25	$8.26B	–	-11.2%	-11.0%	+11.7%
Quarterly EBITDA	Sep 30, 26	$2.16B	-6.3%	+20.3%	+3.7%	-8.1%
Price	Oct 30, 26	$420.07	+11.6%	+30.5%	-6.2%	-3.5%
PE Ratio	Oct 30, 26	17.91	+7.0%	+36.0%	+0.5%	-8.3%
TTM Revenue	Sep 30, 26	$201.83B	+0.4%	+3.6%	+19.7%	+50.8%
TTM EPS	Sep 30, 26	$23.46	+4.3%	-4.1%	-6.7%	+5.3%
	Sep 30, 26	$6.25B	+6.6%	-12.0%	-19.4%	-12.4%
TTM Net Income	Sep 30, 26	$5.10B	+3.1%	-7.7%	-15.5%	-7.6%

TTM EBITDA Highs

ELV TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$8.64B	N/A	-10.4%
3Y	$10.10B	Jun 30, 24	-23.4%
5Y	$10.10B	Jun 30, 24	-23.4%
All	$10.10B	Jun 30, 24	-23.4%

TTM EBITDA Lows

ELV TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$7.38B	Jun 30, 26	+4.9%
3Y	$7.38B	Jun 30, 26	+4.9%
5Y	$7.38B	Jun 30, 26	+4.9%
All	$215.20M	Jun 30, 02	+3496.2%

TTM EBITDA History

Month	Value	Change
Sep 2026	$7.74B	+4.9%
Jun 2026	$7.38B	-4.8%
Mar 2026	$7.74B	-6.2%
Dec 2025	$8.26B	-4.4%
Sep 2025	$8.64B	+1.1%
Jun 2025	$8.55B	-7.1%
Mar 2025	$9.20B	-1.1%
Dec 2024	$9.30B	-4.3%
Sep 2024	$9.72B	-3.7%
Jun 2024	$10.10B	+4.6%
Mar 2024	$9.65B	+2.0%
Dec 2023	$9.46B	-1.0%
Sep 2023	$9.55B	-5.0%
Jun 2023	$10.05B	+3.7%
Mar 2023	$9.69B	+4.5%
Dec 2022	$9.28B	-2.5%
Sep 2022	$9.52B	+2.5%
Jun 2022	$9.29B	-1.6%
Mar 2022	$9.43B	+2.2%
Dec 2021	$9.23B	+10.3%
Sep 2021	$8.37B	+24.6%
Jun 2021	$6.72B	-10.3%
Mar 2021	$7.49B	+1.3%
Dec 2020	$7.39B	-5.7%
Sep 2020	$7.84B	-12.2%
Jun 2020	$8.93B	+23.3%
Mar 2020	$7.24B	+1.8%
Dec 2019	$7.12B	+7.8%
Sep 2019	$6.61B	+4.1%
Jun 2019	$6.35B	-0.6%
Mar 2019	$6.38B	+3.0%
Dec 2018	$6.20B	+8.4%
Sep 2018	$5.72B	+3.4%
Jun 2018	$5.53B	+7.1%
Mar 2018	$5.17B	+6.5%
Dec 2017	$4.85B	-10.0%
Sep 2017	$5.39B	-0.4%
Jun 2017	$5.42B	-4.4%
Mar 2017	$5.67B	+3.6%
Dec 2016	$5.47B	+5.5%
Sep 2016	$5.18B	+5.4%
Jun 2016	$4.92B	-7.1%
Mar 2016	$5.29B	-4.4%
Dec 2015	$5.54B	-8.1%
Sep 2015	$6.03B	-3.2%
Jun 2015	$6.23B	+10.1%
Mar 2015	$5.66B	+8.4%

Month	Value	Change
Dec 2014	$5.22B	+8.2%
Sep 2014	$4.82B	+4.1%
Jun 2014	$4.63B	+0.9%
Mar 2014	$4.59B	-3.1%
Dec 2013	$4.74B	+0.5%
Sep 2013	$4.72B	-2.1%
Jun 2013	$4.82B	+4.5%
Mar 2013	$4.61B	+0.1%
Dec 2012	$4.61B	+0.4%
Sep 2012	$4.59B	+0.3%
Jun 2012	$4.57B	+1.5%
Mar 2012	$4.51B	-1.9%
Dec 2011	$4.60B	-5.2%
Sep 2011	$4.85B	-1.9%
Jun 2011	$4.94B	-2.3%
Mar 2011	$5.06B	+2.1%
Dec 2010	$4.95B	-41.9%
Sep 2010	$8.52B	+0.4%
Jun 2010	$8.48B	+1.0%
Mar 2010	$8.40B	+5.6%
Dec 2009	$7.96B	+93.0%
Sep 2009	$4.12B	+15.7%
Jun 2009	$3.56B	-3.7%
Mar 2009	$3.70B	+0.1%
Dec 2008	$3.69B	-18.2%
Sep 2008	$4.52B	-15.4%
Jun 2008	$5.34B	-2.5%
Mar 2008	$5.48B	-6.3%
Dec 2007	$5.84B	+0.5%
Sep 2007	$5.82B	+2.0%
Jun 2007	$5.70B	+2.1%
Mar 2007	$5.59B	+1.3%
Dec 2006	$5.52B	+4.6%
Sep 2006	$5.28B	+4.5%
Jun 2006	$5.05B	+5.9%
Mar 2006	$4.77B	+5.5%
Dec 2005	$4.52B	+18.2%
Sep 2005	$3.83B	+27.8%
Jun 2005	$3.00B	+27.6%
Mar 2005	$2.35B	+36.0%
Dec 2004	$1.73B	+40.9%
Sep 2004	$1.23B	+39.7%
Jun 2004	$877.30M	+94.4%
Mar 2004	$451.40M	-44.6%
Dec 2002	$815.10M	+66.4%
Sep 2002	$489.70M	+127.6%
Jun 2002	$215.20M	-

FAQ

What is the current TTM EBITDA of ELV?: As of today, ELV TTM EBITDA is $7.74B
What is ELV TTM EBITDA most recent change?: ELV TTM EBITDA was up +4.94% on September 30, 2026
What is 1-year change in ELV TTM EBITDA?: ELV TTM EBITDA is down -10.42% year-over-year
How far is ELV TTM EBITDA from its all-time high?: ELV TTM EBITDA is currently -23.35% below its historical high of $10.10B set on June 30, 2024
How does ELV TTM EBITDA rank versus sector peers?: ELV TTM EBITDA is higher than 97.98% of companies in Healthcare sector
When is ELV next earnings release?: The next earnings release for ELV is on January 28, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ELV Official Website www.elevancehealth.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
ELV Profile on Yahoo Finance finance.yahoo.com/quote/ELV
ELV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elv